Cipriani A - Search Results

1

Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone.

Cipriani A, Barbui C. Cipriani A, et al. Evid Based Ment Health. 2008 Feb;11(1):15. doi: 10.1136/ebmh.11.1.15. Evid Based Ment Health. 2008. PMID: 18223050 No abstract available.

2

Review: selective serotonin reuptake inhibitors as effective as tricyclic antidepressants for major depression, and may have fewer adverse effects.

Cipriani A. Cipriani A. Evid Based Ment Health. 2003 Nov;6(4):117. doi: 10.1136/ebmh.6.4.117. Evid Based Ment Health. 2003. PMID: 14585790 Free article. No abstract available.

3

Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants.

Cipriani A. Cipriani A. Evid Based Ment Health. 2005 Nov;8(4):113. doi: 10.1136/ebmh.8.4.113. Evid Based Ment Health. 2005. PMID: 16246889 Free article. No abstract available.

4

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.

Barbui C, Furukawa TA, Cipriani A. Barbui C, et al. Among authors: cipriani a. CMAJ. 2008 Jan 29;178(3):296-305. doi: 10.1503/cmaj.070693. CMAJ. 2008. PMID: 18227449 Free PMC article.

5

Does the addition of a second antipsychotic drug improve clozapine treatment?

Barbui C, Signoretti A, Mulè S, Boso M, Cipriani A. Barbui C, et al. Among authors: cipriani a. Schizophr Bull. 2009 Mar;35(2):458-68. doi: 10.1093/schbul/sbn030. Epub 2008 Apr 23. Schizophr Bull. 2009. PMID: 18436527 Free PMC article. Review.

6

Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.

Barbui C, Cipriani A, Geddes JR. Barbui C, et al. Among authors: cipriani a. Evid Based Ment Health. 2008 May;11(2):34-5. doi: 10.1136/ebmh.11.2.34. Evid Based Ment Health. 2008. PMID: 18441126 No abstract available.

7

Cognitive improvements with antipsychotics: real or practice effect?

Barbui C, Cipriani A. Barbui C, et al. Among authors: cipriani a. Evid Based Ment Health. 2008 May;11(2):42. doi: 10.1136/ebmh.11.2.42. Evid Based Ment Health. 2008. PMID: 18441131 No abstract available.

8

What is an intention to treat analysis?

Cipriani A, Barbui C. Cipriani A, et al. Epidemiol Psichiatr Soc. 2008 Jan-Mar;17(1):26-7. Epidemiol Psichiatr Soc. 2008. PMID: 18444454 No abstract available.

9

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group. Nakagawa A, et al. Among authors: cipriani a. CNS Drugs. 2008;22(7):587-602. doi: 10.2165/00023210-200822070-00004. CNS Drugs. 2008. PMID: 18547127 Review.

10

Allocation concealment and blinding in clinical trials.

Cipriani A, Nosè M, Barbui C. Cipriani A, et al. Epidemiol Psichiatr Soc. 2008 Apr-Jun;17(2):115-6. Epidemiol Psichiatr Soc. 2008. PMID: 18589626 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters